文献速递胸部肿瘤乳腺癌消化系统肿瘤

人工智能预测癌症风险,我们准备好了吗?跨癌种全面综述

Artificial intelligence to predict cancer risk, are we there yet? A comprehensive review across cancer types.
PubMed 文献 · Eur J Cancer · 2025-04-20

本综述首先概述人工智能技术的现状及其对不同数据类型的适用性,然后综合分析文献中人工智能方法在十九种癌症类型中的应用,评估所用模型、指标和暴露变量,最后讨论人工智能在临床实践中的应用及其潜在局限和未来方向。

要点

  • 综述涵盖膀胱癌、乳腺癌、宫颈癌等十九种癌症类型的人工智能风险预测应用。
  • 评估了各癌种人工智能模型所用的模型、指标和暴露变量。
  • 讨论了人工智能在临床实践中的应用、潜在局限和未来方向。

核心结论

  • 人工智能技术有潜力识别传统方法可能忽略的数据中的复杂模式和关系,尤其适用于处理癌症研究中分析的大型异质数据集。

研究设计与样本

  • 综述首先审视人工智能技术的当前技术水平,然后综合分析文献中人工智能方法在十九种癌症类型中的应用。

主要发现

  • 综述聚焦于人工智能方法在十九种癌症类型(膀胱癌、乳腺癌、宫颈癌、结直肠癌、子宫内膜癌、食管癌、胃癌、妇科癌症、头颈癌、血液系统癌症、肾癌、肝癌、肺癌、黑色素瘤、卵巢癌、胰腺癌、前列腺癌、甲状腺癌和整体癌症)中的应用,评估了所用模型、指标和暴露变量。

临床怎么用

  • 综述讨论了人工智能在临床实践中的应用,并评估其潜在局限和未来方向。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cancer remains the second leading cause of death worldwide, representing a substantial challenge to global health. Although traditional risk prediction models have played a crucial role in epidemiology of several cancer types, they have limitations especially in the ability to process complex and multidimensional data. In contrast, artificial intelligence (AI) approaches represent a promising solution to overcome this limitation. AI techniques have the potential to identify complex patterns and relationships in data that traditional methods might overlook, making them especially useful for handling large and heterogeneous datasets analysed in cancer research. This review first examines the current state of the art of AI techniques, highlighting their differences and suitability for various data types. Then, offers a comprehensive analysis of the literature, focusing on the application of AI approaches in nineteen cancer types (bladder cancer, breast cancer, cervical cancer, colorectal cancer, endometrial cancer, esophageal cancer, gastric cancer, gynaecological cancers, head and neck cancer, haematological cancers, kidney cancer, liver cancer, lung cancer, melanoma, ovarian cancer, pancreatic cancer, prostate cancer, thyroid cancer and overall cancer), evaluating the models, metrics, and exposure variables used. Finally, the review discusses the application of AI in the clinical practice, along with an assessment of its potential limitations and future directions.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Felici A, Peduzzi G, Pellungrini R, et al. Artificial intelligence to predict cancer risk, are we there yet? A comprehensive review across cancer types. Eur J Cancer. 2025. PMID: 40273730. doi:10.1016/j.ejca.2025.115440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。